Faculty members at VCU Massey Cancer Center and the VCU C. Kenneth and Dianne Wright Center for Clinical and Translational Research are expanding the curriculum for the Cancer and Molecular Medicine (CAMM) Ph.D. program at VCU to better meet the nation’s needs for the next generation of cancer scientists.
Massey researcher develops novel vaccine that is effective when combined with immunotherapy in colorectal cancer
In an attempt to boost the immune system’s complete ability to bombard cancer growth and progression, Julian Zhu, Ph.D., member of the Developmental Therapeutics research program at VCU Massey Cancer Center, recently developed a novel vaccine that successfully treated colorectal cancer cells in combination with immune checkpoint inhibitors, which are drugs that inhibit the function of specific proteins. In pre-clinical experiments, the combination demonstrated a complete regression without recurrence in about 60 percent of cancer cells, as indicated by research findings published in Science Advances.
VCU Massey Cancer Center director Robert Winn, M.D., recently joined the boards of directors of two influential cancer organizations, the Association of American Cancer Institutes (AACI) and LUNGevity Foundation.
VCU Massey Cancer Center researcher Charles Clevenger, M.D., Ph.D., has been named associate director for precision oncology at Massey.
VCU Massey Cancer Center has resumed limited visitation for hospitalized non-COVID-19 patients, allowing one adult visitor per day, with some restrictions. Our patient care philosophy depends greatly on engaging family and friends to be part of the healing process. We have adopted safety practices that limit the risk of COVID-19 while allowing visitors back.